| scholarly article | Q13442814 |
| P50 | author | Hope Rugo | Q55975497 |
| Michelle E Melisko | Q92576217 | ||
| P2093 | author name string | John W Park | |
| Mark Jesus M Magbanua | |||
| Janet H Scott | |||
| Jin Sun Lee | |||
| Andrea T Kablanian | |||
| P2860 | cites work | Leptomeningeal metastases: a review of evaluation and treatment | Q41730421 |
| Survival of breast cancer patients with meningeal carcinomatosis | Q43079397 | ||
| Leptomeningeal carcinomatosis: prognostic value of clinical, cerebrospinal fluid, and neuroimaging features | Q43564547 | ||
| Evaluation and significance of circulating epithelial cells in patients with hormone-refractory prostate cancer | Q44367943 | ||
| Clinical outcome of central nervous system metastases from breast cancer: differences in survival depending on systemic treatment | Q44417765 | ||
| Circulating tumor cell analysis in metastatic triple-negative breast cancers | Q46337692 | ||
| Circulating tumour cells in non-metastatic breast cancer: a prospective study | Q47652073 | ||
| Leptomeningeal carcinomatosis. Presenting features and prognostic factors | Q50990635 | ||
| Isolation of rare circulating tumour cells in cancer patients by microchip technology | Q24597164 | ||
| Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases | Q28289395 | ||
| Circulating tumor cells, disease progression, and survival in metastatic breast cancer | Q29619276 | ||
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer | Q30080026 | ||
| Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data | Q30779447 | ||
| The diagnostic accuracy of magnetic resonance imaging and cerebrospinal fluid cytology in leptomeningeal metastasis | Q33179038 | ||
| Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment | Q33491365 | ||
| Leptomeningeal metastases: comparison of clinical features and laboratory data of solid tumors, lymphomas and leukemias | Q33702351 | ||
| Leptomeningeal metastases in the MRI era. | Q33853342 | ||
| Genomic profiling of isolated circulating tumor cells from metastatic breast cancer patients | Q33857819 | ||
| Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis | Q34111187 | ||
| Isolation and genomic analysis of circulating tumor cells from castration resistant metastatic prostate cancer | Q34176352 | ||
| Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. Eastern Cooperative Oncology Group | Q34361329 | ||
| Development of a new method for identification and quantification in cerebrospinal fluid of malignant cells from breast carcinoma leptomeningeal metastasis | Q34474896 | ||
| Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer | Q34790678 | ||
| Circulating tumor cell as a diagnostic marker in primary lung cancer | Q35011135 | ||
| Leptomeningeal metastasis: a Response Assessment in Neuro-Oncology critical review of endpoints and response criteria of published randomized clinical trials | Q35175149 | ||
| Identification and enumeration of circulating tumor cells in the cerebrospinal fluid of breast cancer patients with central nervous system metastases. | Q35640165 | ||
| Genome-wide copy number analysis of cerebrospinal fluid tumor cells and their corresponding archival primary tumors | Q35950754 | ||
| Incidence and time trends of brain metastases admissions among breast cancer patients in Sweden | Q35998465 | ||
| Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force | Q36575967 | ||
| Brain metastases: the HER2 paradigm | Q36760996 | ||
| Rare cell capture technology for the diagnosis of leptomeningeal metastasis in solid tumors | Q36870131 | ||
| Molecular profiling of tumor cells in cerebrospinal fluid and matched primary tumors from metastatic breast cancer patients with leptomeningeal carcinomatosis | Q38394492 | ||
| Isolation of circulating tumor cells by immunomagnetic enrichment and fluorescence-activated cell sorting (IE/FACS) for molecular profiling | Q39118647 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cerebrospinal fluid | Q54196 |
| P304 | page(s) | 339-349 | |
| P577 | publication date | 2015-10-31 | |
| P1433 | published in | Breast Cancer Research and Treatment | Q326085 |
| P1476 | title | Detection of cerebrospinal fluid tumor cells and its clinical relevance in leptomeningeal metastasis of breast cancer. | |
| P478 | volume | 154 |
| Q40078141 | Cerebrospinal fluid circulating tumor cells: a novel tool to diagnose leptomeningeal metastases from epithelial tumors |
| Q50127876 | Clinical significance of detecting CSF-derived tumor cells in breast cancer patients with leptomeningeal metastasis. |
| Q88979450 | Developments in Point-of-Care Diagnostic Technology for Cancer Detection |
| Q57578829 | EANO–ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with leptomeningeal metastasis from solid tumours† |
| Q49384451 | EpCAM-based assays for epithelial tumor cell detection in cerebrospinal fluid |
| Q50114923 | Expanded genomic profiling of circulating tumor cells in metastatic breast cancer patients to assess biomarker status and biology over time |
| Q51115531 | Improving the CellSearch® system |
| Q64241627 | Liquid biopsy in central nervous system metastases: a RANO review and proposals for clinical applications |
| Q54950354 | Mechanisms and Therapy for Cancer Metastasis to the Brain. |
| Q26741320 | Molecular Targeted Therapies for the Treatment of Leptomeningeal Carcinomatosis: Current Evidence and Future Directions |
| Q90462003 | New Frontiers in Diagnosis and Therapy of Circulating Tumor Markers in Cerebrospinal Fluid In Vitro and In Vivo |
| Q93002945 | Novel methods to diagnose leptomeningeal metastases in breast cancer |
| Q39613259 | SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis). |
| Q89018078 | The Utility of Liquid Biopsy in Central Nervous System Malignancies |
Search more.